- US FDA approves Glenmark's oral contraceptives 24 February 2016
- Glenmark to raise Rs 945 crore from Temasek Holdings 17 April 2015
- HC blocks Glenmark from selling US firm's diabetes drug 20 March 2015
- Glenmark wins favourable interim order in deal with Napo 14 January 2012
- Glenmark to market Crofelemer despite Napo nix 15 December 2011
- US FDA approves Glenmark's corticosteroid 10 August 2010
- Merck settles Zetia patent suit with Glenmark 11 May 2010
- Glenmark launches Prasugrel for heart patients in India 29 April 2010
- Glenmark launches two new generics in UK 07 April 2010
- Glenmark gets nod to market skin cream in US 16 November 2009
- Glenmark, Forest drug trial for COPD fails 19 August 2009
- Glenmark faces GSK patent challenge in US over malaria drug 18 August 2009
- Glenmark to withdraw painkiller from US market 02 April 2009
- Glenmark gets US FDA approval for marketing Ranitidine 21 November 2008
- Glenmark launches `Azathioprine' tablets in US 20 November 2008
- Glenmark starts selling pain killer drugs in US 10 November 2008
- Exelixis says GSK drug research deal to end 24 October 2008
- Glenmark gets nod for marketing two drugs in US 30 May 2008
- US FDA approves Glenmark Pharmaceuticals Baddi semi-solids plant 28 January 2008
- Glenmark Pharma to spin off generics unit, list new unit next year 17 November 2007
- Glenmark signs up marketing deal with MyerZall Labs 27 October 2007
- Merck pays Glenmark Rs148 crore upfront for diabetes drug 19 December 2006
- Glenmark to start clinical trials of painkiller in Europe 14 December 2006
- Glenmark signs an additional deal for seven ANDAs with LVT 07 December 2006
- Glenmark gets DCGI nod for Phase II trials of diarrhoea drug 03 August 2006
- Glenmark Pharmaceuticals announces new drug discovery for obesity 13 February 2006
- Glenmark Pharmaceuticals targets GPs 10 October 2005
- Glenmark acquires another brand in Brazil 18 March 2005
- Glenmark Pharmaceuticals plans major foray into US markets 08 October 2003
- Glenmark Pharmaceuticals to divest subsidiary for Rs 35 crore 10 February 2003
